标题
Omega-3 and cardiovascular prevention – Is this still a choice?
作者
关键词
-
出版物
PHARMACOLOGICAL RESEARCH
Volume 182, Issue -, Pages 106342
出版商
Elsevier BV
发表日期
2022-07-04
DOI
10.1016/j.phrs.2022.106342
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Changes in eicosapentaenoic acid and docosahexaenoic acid and risk of cardiovascular events and atrial fibrillation: A secondary analysis of the OMEMI trial
- (2022) Peder L. Myhre et al. JOURNAL OF INTERNAL MEDICINE
- Rationale for different formulations of omega-3 fatty acids leading to differences in residual cardiovascular risk reduction
- (2022) Preston Mason et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- The Role of High-Density Lipoprotein Cholesterol in 2022
- (2022) Cesare R. Sirtori et al. Current Atherosclerosis Reports
- Effect of Long-term Supplementation With Marine Omega-3 Fatty Acids vs Placebo on Risk of Depression
- (2022) Mu-Hong Chen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Prevention of Cardiovascular Events and Mortality With Icosapent Ethyl in Patients With Prior Myocardial Infarction
- (2022) Prakriti Gaba et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Impact of Icosapent Ethyl on Cardiovascular Risk Reduction in Patients With Heart Failure in REDUCE‐IT
- (2022) Senthil Selvaraj et al. Journal of the American Heart Association
- Omega‐3 Polyunsaturated Fatty Acids Intake and Blood Pressure: A Dose‐Response Meta‐Analysis of Randomized Controlled Trials
- (2022) Xin Zhang et al. Journal of the American Heart Association
- Diabetes Mellitus, Race, and Effects of Omega-3 Fatty Acids on Incidence of Heart Failure Hospitalization
- (2022) Luc Djoussé et al. JACC-Heart Failure
- Effects of Randomized Treatment With Icosapent Ethyl and a Mineral Oil Comparator on Interleukin-1β, Interleukin-6, C-Reactive Protein, Oxidized Low-Density Lipoprotein Cholesterol, Homocysteine, Lipoprotein(a), and Lipoprotein-Associated Phospholipase A2: A REDUCE-IT Biomarker Substudy
- (2022) Paul M Ridker et al. CIRCULATION
- Linoleic acid in adipose tissue and the risk of myocardial infarction: a case–cohort study
- (2021) Maja H. Nielsen et al. EUROPEAN JOURNAL OF NUTRITION
- Cardiovascular Impact of Nutritional Supplementation With Omega-3 Fatty Acids
- (2021) Richard L. Weinberg et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Mechanistic Insights from REDUCE-IT STRENGTHen the Case Against Triglyceride Lowering as a Strategy for Cardiovascular Disease Risk Reduction
- (2021) R. Preston Mason et al. AMERICAN JOURNAL OF MEDICINE
- Omega-3 fatty acids ameliorate vascular inflammation: A rationale for their atheroprotective effects
- (2021) Anthony D. Pisaniello et al. ATHEROSCLEROSIS
- EPA and DHA differentially modulate membrane elasticity in the presence of cholesterol
- (2021) Miranda L. Jacobs et al. BIOPHYSICAL JOURNAL
- An abundant biliary metabolite derived from dietary omega-3 polyunsaturated fatty acids regulates triglycerides
- (2021) Trisha J. Grevengoed et al. JOURNAL OF CLINICAL INVESTIGATION
- Apolipoprotein B and Non-HDL Cholesterol Better Reflect Residual Risk Than LDL Cholesterol in Statin-Treated Patients
- (2021) Camilla Ditlev Lindhardt Johannesen et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Blood n-3 fatty acid levels and total and cause-specific mortality from 17 prospective studies
- (2021) William S. Harris et al. Nature Communications
- Plasma Omega‐3 Fatty Acids and the Risk of Cardiovascular Events in Patients After an Acute Coronary Syndrome in MERLIN‐TIMI 36
- (2021) Thomas A. Zelniker et al. Journal of the American Heart Association
- Association Between Achieved ω-3 Fatty Acid Levels and Major Adverse Cardiovascular Outcomes in Patients With High Cardiovascular Risk
- (2021) Steven E. Nissen et al. JAMA Cardiology
- Using an erythrocyte fatty acid fingerprint to predict risk of all-cause mortality: the Framingham Offspring Cohort
- (2021) Michael I McBurney et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- A possible explanation for the contrasting results of REDUCE-IT vs. STRENGTH: cohort study mimicking trial designs
- (2021) Takahito Doi et al. EUROPEAN HEART JOURNAL
- Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society
- (2021) Henry N Ginsberg et al. EUROPEAN HEART JOURNAL
- Omega-3 Versus Omega-6 Fatty Acid Availability is Controlled by Hydrophobic Site Geometries of Phospholipase A2s
- (2021) Daiki Hayashi et al. JOURNAL OF LIPID RESEARCH
- Advances in Technologies for Highly Active Omega-3 Fatty Acids from Krill Oil: Clinical Applications
- (2021) Alessandro Colletti et al. Marine Drugs
- Impact of nutraceuticals on markers of systemic inflammation: Potential relevance to cardiovascular diseases – A position paper from the International Lipid Expert Panel (ILEP)
- (2021) Massimiliano Ruscica et al. PROGRESS IN CARDIOVASCULAR DISEASES
- Vascepa protects against high-fat diet-induced glucose intolerance, insulin resistance, and impaired β-cell function
- (2021) Dana Al Rijjal et al. iScience
- Dietary intake and plasma concentrations of PUFAs in childhood and adolescence in relation to asthma and lung function up to adulthood
- (2021) Sandra Ekström et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Icosapent Ethyl Reduces Ischemic Events in Patients With a History of Previous Coronary Artery Bypass Grafting: REDUCE-IT CABG
- (2021) Subodh Verma et al. CIRCULATION
- Benefits of Icosapent Ethyl Across the Range of Kidney Function in Patients With Established Cardiovascular Disease or Diabetes: REDUCE-IT RENAL
- (2021) Arjun Majithia et al. CIRCULATION
- Effect of Long-Term Marine ɷ-3 Fatty Acids Supplementation on the Risk of Atrial Fibrillation in Randomized Controlled Trials of Cardiovascular Outcomes: A Systematic Review and Meta-Analysis
- (2021) Baris Gencer et al. CIRCULATION
- Investigating contrasting results in REDUCE-IT and STRENGTH: partial answers but questions remain
- (2021) Kevin C Maki EUROPEAN HEART JOURNAL
- The reduction in cardiovascular risk in REDUCE-IT is due to eicosapentaenoic acid in icosapent ethyl
- (2021) Ph Gabriel Steg et al. EUROPEAN HEART JOURNAL
- Lipoprotein(a): Knowns, unknowns and uncertainties
- (2021) Massimiliano Ruscica et al. PHARMACOLOGICAL RESEARCH
- Dietary intake and biomarkers of linoleic acid and mortality: systematic review and meta-analysis of prospective cohort studies
- (2020) Jun Li et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Emerging Mechanisms of Cardiovascular Protection for the Omega-3 Fatty Acid Eicosapentaenoic Acid
- (2020) R. Preston Mason et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Cholesterol crystals and atherosclerosis
- (2020) Yvonne Baumer et al. EUROPEAN HEART JOURNAL
- The Evolving Understanding and Approach to Residual Cardiovascular Risk Management
- (2020) Devinder S. Dhindsa et al. Frontiers in Cardiovascular Medicine
- Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: final results of the EVAPORATE trial
- (2020) Matthew J Budoff et al. EUROPEAN HEART JOURNAL
- Mineral oil: safety and use as placebo in REDUCE-IT and other clinical studies
- (2020) Brian Olshansky et al. EUROPEAN HEART JOURNAL SUPPLEMENTS
- Effect of Omega-3 Dosage on Cardiovascular Outcomes
- (2020) Aldo A. Bernasconi et al. MAYO CLINIC PROCEEDINGS
- Omega-3 polyunsaturated fatty acids supplementation and cardiovascular outcomes: do formulation, dosage, and baseline cardiovascular risk matter? An updated meta-analysis of randomized controlled trials
- (2020) Manuela Casula et al. PHARMACOLOGICAL RESEARCH
- REDUCE-IT INTERIM: Accumulation of Data Across Prespecified Interim Analyses to Final Results
- (2020) Brian Olshansky et al. European Heart Journal-Cardiovascular Pharmacotherapy
- Reduction in Revascularization With Icosapent Ethyl
- (2020) Benjamin E. Peterson et al. CIRCULATION
- Effects of n-3 Fatty Acid Supplements in Elderly Patients after Myocardial Infarction: A Randomized Controlled Trial
- (2020) Are Annesønn Kalstad et al. CIRCULATION
- Omega-3 fatty acids
- (2020) Philip C. Calder et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- Effects of Omega-3 Fatty Acids on Major Adverse Cardiovascular Events
- (2020) Garima Sharma et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk
- (2020) Stephen J. Nicholls et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Receptors for pro-resolving mediators as a therapeutic tool for smooth muscle remodeling-associated disorders
- (2020) Gregory Livshits et al. PHARMACOLOGICAL RESEARCH
- Controversies about the cardiovascular effects of OM3FA. Did inappropriate placebos skew clinical trial results?
- (2020) Fernando Martins do Vale et al. PHARMACOLOGICAL RESEARCH
- Effects of Icosapent Ethyl on Total Ischemic Events: From REDUCE-IT
- (2019) Deepak L. Bhatt et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- n-3 PUFAs improve erythrocyte fatty acid profile in patients with small abdominal aortic aneurysms: a randomised controlled trial
- (2019) Lara T. Meital et al. JOURNAL OF LIPID RESEARCH
- Anticytokine Agents
- (2019) Paul M Ridker CIRCULATION RESEARCH
- Biomarkers of Dietary Omega-6 Fatty Acids and Incident Cardiovascular Disease and Mortality
- (2019) Matti Marklund et al. CIRCULATION
- Preferential Incorporation of Administered Eicosapentaenoic Acid Into Thin-Cap Atherosclerotic Plaques
- (2019) Tomohito Sato et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Immunonutrition for Adults With ARDS: Results From a Cochrane Systematic Review and Meta-Analysis
- (2019) Ahilanandan Dushianthan et al. Respiratory Care
- Supplementation with Vitamin D and/or Omega-3 Fatty Acids and Incidence of Heart Failure Hospitalization: VITAL-Heart Failure
- (2019) Luc Djoussé et al. CIRCULATION
- Dietary linoleic acid and human health: Focus on cardiovascular and cardiometabolic effects
- (2019) Franca Marangoni et al. ATHEROSCLEROSIS
- Comparison of mineral oil and non-mineral oil placebo on coronary plaque progression by coronary computed tomography angiography
- (2019) Suvasini Lakshmanan et al. CARDIOVASCULAR RESEARCH
- Profound reductions in first and total cardiovascular events with icosapent ethyl in the REDUCE-IT trial: why these results usher in a new era in dyslipidaemia therapeutics
- (2019) William E Boden et al. EUROPEAN HEART JOURNAL
- Efficacy of fish oil and its components in the management of psoriasis: a systematic review of 18 randomized controlled trials
- (2019) Xi Chen et al. NUTRITION REVIEWS
- Eicosapentaenoic acid and docosahexaenoic acid have distinct membrane locations and lipid interactions as determined by X-ray diffraction
- (2018) Samuel C.R. Sherratt et al. CHEMISTRY AND PHYSICS OF LIPIDS
- Eicosapentaenoic Acid-Enriched High-Density Lipoproteins Exhibit Anti-Atherogenic Properties
- (2018) Nobuaki Tanaka et al. CIRCULATION JOURNAL
- PPAR Agonists and Metabolic Syndrome: An Established Role?
- (2018) Margherita Botta et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators
- (2018) Charles N. Serhan et al. JOURNAL OF CLINICAL INVESTIGATION
- The role of non-resolving inflammation in atherosclerosis
- (2018) Canan Kasikara et al. JOURNAL OF CLINICAL INVESTIGATION
- N-3 polyunsaturated fatty acids for prevention of postoperative atrial fibrillation: updated meta-analysis and systematic review
- (2018) Hao Wang et al. JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY
- Unmet Need for Adjunctive Dyslipidemia Therapy in Hypertriglyceridemia Management
- (2018) Om P. Ganda et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Two polymorphic cholesterol monohydrate crystal structures form in macrophage culture models of atherosclerosis
- (2018) Neta Varsano et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Omega-6 fatty acids and inflammation
- (2018) Jacqueline K. Innes et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- Effects of n−3 Fatty Acid Supplements in Diabetes Mellitus
- (2018) NEW ENGLAND JOURNAL OF MEDICINE
- Marine n−3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer
- (2018) JoAnn E. Manson et al. NEW ENGLAND JOURNAL OF MEDICINE
- FISHing for the Miracle of Eicosapentaenoic Acid
- (2018) John J.P. Kastelein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
- (2018) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Systemic Bioavailability and Dose Proportionality of Omega-3 Administered in Free Fatty Acid Form Compared With Ethyl Ester Form: Results of a Phase 1 Study in Healthy Volunteers
- (2017) Elliot Offman et al. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
- EPA:DHA 6:1 prevents angiotensin II-induced hypertension and endothelial dysfunction in rats: role of NADPH oxidase- and COX-derived oxidative stress
- (2017) Zahid Rasul Niazi et al. HYPERTENSION RESEARCH
- A randomized controlled trial of eicosapentaenoic acid in patients with coronary heart disease on statins
- (2017) Tetsu Watanabe et al. Journal of Cardiology
- Very long-chain n-3 fatty acids and human health: fact, fiction and the future
- (2017) P. C. Calder PROCEEDINGS OF THE NUTRITION SOCIETY
- Circulating inflammation-resolving lipid mediators RvD1 and DHA are decreased in patients with acutely symptomatic carotid disease
- (2017) Hernan A. Bazan et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- Low salivary resolvin D1 to leukotriene B4 ratio predicts carotid intima media thickness: A novel biomarker of non-resolving vascular inflammation
- (2017) Silke Thul et al. European Journal of Preventive Cardiology
- Effect of Eicosapentaenoic and Docosahexaenoic Acids Added to Statin Therapy on Coronary Artery Plaque in Patients With Coronary Artery Disease: A Randomized Clinical Trial
- (2017) Abdulhamied Alfaddagh et al. Journal of the American Heart Association
- A randomized, crossover, head-to-head comparison of eicosapentaenoic acid and docosahexaenoic acid supplementation to reduce inflammation markers in men and women: the Comparing EPA to DHA (ComparED) Study
- (2016) Janie Allaire et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Icosapent ethyl (eicosapentaenoic acid ethyl ester): Effects on remnant-like particle cholesterol from the MARINE and ANCHOR studies
- (2016) Christie M. Ballantyne et al. ATHEROSCLEROSIS
- Eicosapentaenoic acid reduces membrane fluidity, inhibits cholesterol domain formation, and normalizes bilayer width in atherosclerotic-like model membranes
- (2016) R. Preston Mason et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease
- (2016) Børge G. Nordestgaard CIRCULATION RESEARCH
- From C-Reactive Protein to Interleukin-6 to Interleukin-1
- (2016) Paul M Ridker CIRCULATION RESEARCH
- Docosapentaenoic acid derived metabolites and mediators – The new world of lipid mediator medicine in a nutshell
- (2016) Karsten-H. Weylandt EUROPEAN JOURNAL OF PHARMACOLOGY
- Eicosapentaenoic Acid Inhibits Oxidation of ApoB-containing Lipoprotein Particles of Different Size In Vitro When Administered Alone or in Combination With Atorvastatin Active Metabolite Compared With Other Triglyceride-lowering Agents
- (2016) R. Preston Mason et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- ω-3 Fatty Acid Ethyl Esters Diminish Postprandial Lipemia in Familial Hypercholesterolemia
- (2016) Dick C. Chan et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A Test in Context
- (2016) Paul M Ridker JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques
- (2016) Gabrielle Fredman et al. Nature Communications
- Biologic plausibility, cellular effects, and molecular mechanisms of eicosapentaenoic acid (EPA) in atherosclerosis
- (2015) Kenneth M. Borow et al. ATHEROSCLEROSIS
- Red blood cell fatty acids and biomarkers of inflammation: A cross-sectional study in a community-based cohort
- (2015) João D. Fontes et al. ATHEROSCLEROSIS
- How polyunsaturated fatty acids modify molecular organization in membranes: Insight from NMR studies of model systems
- (2015) Saame Raza Shaikh et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Marine omega-3 fatty acids and inflammatory processes: Effects, mechanisms and clinical relevance
- (2015) Philip C. Calder BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Cytosolic phospholipase A2: physiological function and role in disease
- (2015) Christina C. Leslie JOURNAL OF LIPID RESEARCH
- Saturated Fats Compared With Unsaturated Fats and Sources of Carbohydrates in Relation to Risk of Coronary Heart Disease
- (2015) Yanping Li et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Association of Dietary, Circulating, and Supplement Fatty Acids With Coronary Risk
- (2014) Rajiv Chowdhury et al. ANNALS OF INTERNAL MEDICINE
- Cellular and Molecular Electrophysiology of Atrial Fibrillation Initiation, Maintenance, and Progression
- (2014) Jordi Heijman et al. CIRCULATION RESEARCH
- Very long chain omega-3 (n-3) fatty acids and human health
- (2014) Philip C. Calder EUROPEAN JOURNAL OF LIPID SCIENCE AND TECHNOLOGY
- Effect of purified eicosapentaenoic acid on red cell distribution width in patients with ischemic heart disease
- (2014) Masao Takahashi et al. HEART AND VESSELS
- Pro-resolving lipid mediators are leads for resolution physiology
- (2014) Charles N. Serhan NATURE
- Plasma Phospholipid Long-Chain ω-3 Fatty Acids and Total and Cause-Specific Mortality in Older Adults
- (2013) Dariush Mozaffarian et al. ANNALS OF INTERNAL MEDICINE
- Resolution phase lipid mediators of inflammation: agonists of resolution
- (2013) Charles N. Serhan et al. CURRENT OPINION IN PHARMACOLOGY
- Effects of high dose intravenous fish oil on human atrial electrophysiology: Implications for possible anti- and pro-arrhythmic mechanisms in atrial fibrillation
- (2013) Saurabh Kumar et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Incorporation of eicosapentaenoic and docosahexaenoic acids into lipid pools when given as supplements providing doses equivalent to typical intakes of oily fish
- (2012) Lucy M Browning et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Docosahexaenoic and Eicosapentaenoic Acids Segregate Differently between Raft and Nonraft Domains
- (2012) Justin A. Williams et al. BIOPHYSICAL JOURNAL
- Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology?
- (2012) Philip C. Calder BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Mechanisms of Action of (n-3) Fatty Acids
- (2012) Philip C. Calder JOURNAL OF NUTRITION
- Remnant Cholesterol as a Causal Risk Factor for Ischemic Heart Disease
- (2012) Anette Varbo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- n–3 Fatty Acids and Cardiovascular Outcomes in Patients with Dysglycemia
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Fish oil — How does it reduce plasma triglycerides?
- (2011) Gregory C. Shearer et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Relationships between Plasma Fatty Acid Composition and Coronary Artery Disease
- (2011) Hiroshige Itakura et al. Journal of Atherosclerosis and Thrombosis
- Eicosapentaenoic acid (EPA) from highly concentrated n−3 fatty acid ethyl esters is incorporated into advanced atherosclerotic plaques and higher plaque EPA is associated with decreased plaque inflammation and increased stability
- (2010) Abbie L. Cawood et al. ATHEROSCLEROSIS
- Docosahexaenoic acid prevents dendritic cell maturation, inhibits antigen-specific Th1/Th17 differentiation and suppresses experimental autoimmune encephalomyelitis
- (2010) Weimin Kong et al. BRAIN BEHAVIOR AND IMMUNITY
- GPR120 Is an Omega-3 Fatty Acid Receptor Mediating Potent Anti-inflammatory and Insulin-Sensitizing Effects
- (2010) Da Young Oh et al. CELL
- Eicosapentaenoic Acid Prevents and Reverses Insulin Resistance in High-Fat Diet-Induced Obese Mice via Modulation of Adipose Tissue Inflammation
- (2010) Nishan S. Kalupahana et al. JOURNAL OF NUTRITION
- Genetic Loci Associated With C-Reactive Protein Levels and Risk of Coronary Heart Disease
- (2009) Paul Elliott JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Red Blood Cell Fatty Acid Patterns and Acute Coronary Syndrome
- (2009) Gregory C. Shearer et al. PLoS One
- High-Sensitivity C-Reactive Protein and Lipoprotein-Associated Phospholipase A 2 Stability Before and After Stroke and Myocardial Infarction
- (2009) Mitchell S.V. Elkind et al. STROKE
- Anti-Inflammatory and Proresolving Lipid Mediators
- (2008) Charles N. Serhan et al. Annual Review of Pathology-Mechanisms of Disease
- Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: Sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS)
- (2008) Yasushi Saito et al. ATHEROSCLEROSIS
- Docosahexaenoic Acid Enhances Segregation of Lipids between Raft and Nonraft Domains: 2H-NMR Study
- (2008) Smita P. Soni et al. BIOPHYSICAL JOURNAL
- Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial
- (2008) GISSI-HF investigators LANCET
- Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake
- (2008) Leanne Hodson et al. PROGRESS IN LIPID RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started